BioCryst Pharmaceuticals
BCRX
$4.21
Share price
-3.88%
Change (1 day)
-44.68%
Change (1 year)
Categories
Earnings for BioCryst Pharmaceuticals (BCRX)
Earnings in 2023 (TTM): -$0.23 B
According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.23 B. In 2022 the company made an earning of -$0.25 B a decrease over its 2021 earnings that were of -$0.19 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for BioCryst Pharmaceuticals from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.23 B | -7.43% |
| 2022 | -$0.25 B | 34.42% |
| 2021 | -$0.19 B | -0.55% |
| 2020 | -$0.19 B | 67.88% |
| 2019 | -$0.11 B | 7.55% |
| 2018 | -$0.11 B | 53.92% |
| 2017 | -$65.79 M | 19.29% |
| 2016 | -$55.15 M | 28.19% |
| 2015 | -$43.02 M | -4.8% |
| 2014 | -$45.19 M | 50.09% |
| 2013 | -$30.11 M | -23.29% |
| 2012 | -$39.25 M | -26.19% |
| 2011 | -$53.18 M | 54.78% |
| 2010 | -$34.36 M | 150.1% |
| 2009 | -$13.74 M | -49.43% |
| 2008 | -$27.17 M | 14.07% |
| 2007 | -$23.82 M | -49.31% |
| 2006 | -$46.98 M | 72.87% |
| 2005 | -$27.18 M | 22.08% |
| 2004 | -$22.27 M | 75.3% |
| 2003 | -$12.7 M | -25.36% |
| 2002 | -$17.02 M | 225.05% |
| 2001 | -$5.24 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $6.85 B | -3,131.88% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.53 B | -3,430.70% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | -$0.53 B | 129.90% | 🇺🇸 USA |
 Repligen
RGEN | $66.08 M | -129.21% | 🇺🇸 USA |
 Novavax NVAX | -$0.53 B | 133.66% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$0.15 B | -37.21% | 🇺🇸 USA |
 NanoViricides NNVC | -$9.36 M | -95.86% | 🇺🇸 USA |
 Cel-Sci
CVM | -$30.33 M | -86.59% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$0.65 B | 184.58% | 🇺🇸 USA |